Francois Lebel
Chief Tech/Sci/R&D Officer presso SIRNAOMICS LTD.
Profilo
Francois Lebel is currently the Chief Medical Officer at Sirnaomics Ltd.
He previously held positions as Vice President-Research & Development at Baxter International, Inc. from 2011 to 2012, Chief Medical Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2018 to 2022, Chief Medical Officer and EVP-Research & Development at Alaunos Therapeutics, Inc. from 2013 to 2018, and Vice President-Medical & Scientific Affairs at Medimmune, Inc. from 2004 to 2006.
Dr. Lebel obtained undergraduate and doctorate degrees from the University of Ottawa.
Posizioni attive di Francois Lebel
| Società | Posizione | Inizio |
|---|---|---|
| SIRNAOMICS LTD. | Chief Tech/Sci/R&D Officer | 28/07/2023 |
Precedenti posizioni note di Francois Lebel
| Società | Posizione | Fine |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2022 |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 26/10/2018 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2012 |
| Medimmune, Inc. | Chief Tech/Sci/R&D Officer | 01/09/2006 |
Formazione di Francois Lebel
| University of Ottawa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
| Medimmune, Inc. | Health Technology |
- Borsa valori
- Insiders
- Francois Lebel
